EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prdm1 positively regulates liver Group 1 ILCs cancer immune surveillance and preserves functional heterogeneity

Jitian He iD, Le Gao, Peiying Wang, Wing Keung Chan iD, Yiran Zheng, Yumo Zhang, Jiaman Sun, Xue Li, Jiming Wang, Xiao-Hong Li, Huaiyong Chen, Zhouxin Yang und 1 weitere

eLife · 2024

DOI: 10.7554/elife.92948 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Jitian He und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Engineering & Translational Medicine, Tianjin University, Tianjin, China. Hauptthemen laut MEDLINE: Positive Regulatory Domain I-Binding Factor 1, Mice, Knockout, Liver Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Plan of China, National Natural Science Foundation of China, The Zhejiang Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Group 1 innate lymphoid cells (ILCs) comprise conventional natural killer (cNK) cells and type 1 innate lymphoid cells (ILC1s). The main functions of liver cNK cells and ILC1s not only include directly killing target cells but also regulating local immune microenvironment of the liver through the secretion of cytokines. Uncovering the intricate mechanisms by which transcriptional factors regulate and influence the functions of liver cNK cells and ILC1s, particularly within the context of liver tumors, presents a significant opportunity to amplify the effectiveness of immunotherapies against liver malignancies. Using Ncr1-drived conditional knockout mouse model, our study reveals the regulatory role of Prdm1 in shaping the composition and maturation of cNK cells. Although Prdm1 did not affect the killing function of cNK cells in an in vivo cytotoxicity model, a significant increase in cancer metastasis was observed in Prdm1 knockout mice. Interferon-gamma (IFN-γ), granzyme B, and perforin secretion decreased significantly in Prdm1 -deficient cNK cells and liver ILC1s. Single-cell RNA sequencing (scRNA-seq) data also provided evidences that Prdm1 maintains functional subsets of cNK cells and liver ILC1s and facilitates communications between cNK cells, liver ILC1s, and macrophages. The present study unveiled a novel regulatory mechanism of Prdm1 in cNK cells and liver ILC1s, showing promising potential for developing innovative immune therapy strategies against liver cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positive Regulatory Domain I-Binding Factor 1Mice, KnockoutLiver NeoplasmsAnimalsMiceKiller Cells, NaturalInterferon-gammaImmunity, InnateLymphocytesImmunologic SurveillanceGranzymesNatural Cytotoxicity Triggering Receptor 1PerforinLiverMice, Inbred C57BLTumor MicroenvironmentAntigens, Ly

Stichwörter der Autor:innen

immune surveillanceimmunologyinflammationinnate lymphoid cellslivermouse

Substanzen

Positive Regulatory Domain I-Binding Factor 1Prdm1 protein, mouseInterferon-gammaGranzymesNcr1 protein, mouseNatural Cytotoxicity Triggering Receptor 1PerforinGzmb protein, mouseAntigens, Ly

Autor:innen und Institutionen

  • Institute of Medical Engineering & Translational Medicine, Tianjin University, Tianjin, China.
  • Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, United States.
  • Department of Basic Medicine, Haihe Hospital, Tianjin University, Tianjin, China.
  • Tianjin Economic-Technological Development Area (TEDA) Hospital, Tianjin, China.
  • College of Pulmonary and Critical Care Medicine, 8th Medical Center, Chinese PLA General Hospital, Beijing, China.

ORCID-Profile: Jitian He, Wing Keung Chan, Youwei Wang

Förderung

  • National Key Research and Development Plan of China
  • National Natural Science Foundation of China
  • The Zhejiang Provincial Natural Science Foundation of China
  • Natural Science Foundation of Tianjin
  • Science and Technology Planning Project of Tianjin Municipal Education Commission

Zitieren

APA

He, J., Gao, L., Wang, P., Chan, W. K., Zheng, Y., Zhang, Y., Sun, J., Li, X., Wang, J., Li, X. H., Chen, H., Yang, Z., & Wang, Y. (2024). Prdm1 positively regulates liver Group 1 ILCs cancer immune surveillance and preserves functional heterogeneity. eLife. https://doi.org/10.7554/elife.92948

Vancouver

He J, Gao L, Wang P, Chan WK, Zheng Y, Zhang Y, et al. Prdm1 positively regulates liver Group 1 ILCs cancer immune surveillance and preserves functional heterogeneity. eLife. 2024. doi:10.7554/elife.92948

BibTeX
@article{He2024,
  author = {He, Jitian and Gao, Le and Wang, Peiying and Chan, Wing Keung and Zheng, Yiran and Zhang, Yumo and Sun, Jiaman and Li, Xue and Wang, Jiming and Li, Xiao-Hong and Chen, Huaiyong and Yang, Zhouxin and Wang, Youwei},
  title = {Prdm1 positively regulates liver Group 1 ILCs cancer immune surveillance and preserves functional heterogeneity},
  journal = {eLife},
  year = {2024},
  doi = {10.7554/elife.92948}
}
Kostenlos starten →